Clinical Trial Update: Statins for Acutely Injured Lungs From Sepsis [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating statins for sepsis-associated acute lung injury was terminated, and the results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Injury
• Sepsis

Drugs mentioned

• Statin (unspecified)

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Sepsis, Acute Lung Injury | Phase 3 | Status: TERMINATED | Results posted: 2014-10-03